365 A Phase 1b Open-label, Dose-escalation Study of the Safety and Pharmacology of GDC-0941 in Combination with Erlotinib in Patients with Advanced Solid Tumors

Saved in:

Bibliographic Details
Published in	European journal of cancer (1990) Vol. 48; pp. 111 - 112
Main Authors	Lolkema, M, Leong, S, Voest, E, Freas, E, Shankar, G, Brachmann, R.K, Moss, R.A, Stein, M.N, Mergui-Roelvink, M, Schellens, J.H.M
Format	Journal Article
Language	English
Published	Elsevier Ltd 01.11.2012
Subjects	Hematology, Oncology and Palliative Medicine
Online Access	Get full text

Loading…

More Information
ISSN:	0959-8049 1879-0852
DOI:	10.1016/S0959-8049(12)72163-9